Literature DB >> 16288748

Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.

Thomas Arnesen1, Xianguo Kong, Rune Evjenth, Darina Gromyko, Jan Erik Varhaug, Zhao Lin, Nianli Sang, Jaime Caro, Johan R Lillehaug.   

Abstract

Hypoxia inducible factor-1 alpha (HIF-1 alpha) is a central component of the cellular responses to hypoxia. Hypoxic conditions result in stabilization of HIF-1 alpha and formation of the transcriptionally active HIF-1 complex. It was suggested that mammalian ARD1 acetylates HIF-1 alpha and thereby enhances HIF-1 alpha ubiquitination and degradation. Furthermore, ARD1 was proposed to be down-regulated in hypoxia thus facilitating the stabilization of HIF-1 alpha. Here we demonstrate that the level of human ARD1 (hARD1) protein is not decreased in hypoxia. Moreover, hARD1 does not acetylate and destabilize HIF-1 alpha. However, we find that hARD1 specifically binds HIF-1 alpha, suggesting a putative, still unclear, connection between these proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288748      PMCID: PMC4505811          DOI: 10.1016/j.febslet.2005.10.036

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

1.  Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae.

Authors:  B Polevoda; J Norbeck; H Takakura; A Blomberg; F Sherman
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

2.  An episomal vector for stable tetracycline-regulated gene expression.

Authors:  M Jost; C Kari; U Rodeck
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 3.  Hydroxylation of HIF-1: oxygen sensing at the molecular level.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2004-08

Review 4.  The role of hypoxia-induced factors in tumor progression.

Authors:  Peter Vaupel
Journal:  Oncologist       Date:  2004

Review 5.  Tumor hypoxia and cancer progression.

Authors:  Jie Zhou; Tobias Schmid; Steffen Schnitzer; Bernhard Brüne
Journal:  Cancer Lett       Date:  2005-07-05       Impact factor: 8.679

Review 6.  The hypoxia-inducible factor and tumor progression along the angiogenic pathway.

Authors:  M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Int Rev Cytol       Date:  2005

7.  Analysis of ARD1 function in hypoxia response using retroviral RNA interference.

Authors:  Tim S Fisher; Shelley Des Etages; Lisa Hayes; Kim Crimin; Baiyong Li
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

Review 8.  HIFs and tumors--causes and consequences.

Authors:  Gisele Höpfl; Omolara Ogunshola; Max Gassmann
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-04       Impact factor: 3.619

9.  An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development.

Authors:  Naoaki Sugiura; Suzanne M Adams; Roderick A Corriveau
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

Review 10.  Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.

Authors:  Till Acker; Karl H Plate
Journal:  Cell Tissue Res       Date:  2003-07-29       Impact factor: 5.249

View more
  44 in total

Review 1.  The torments of the cohesin ring.

Authors:  Alap P Chavda; Keven Ang; Dmitri Ivanov
Journal:  Nucleus       Date:  2017-02-27       Impact factor: 4.197

2.  The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.

Authors:  Robert S Magin; Zachary M March; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

3.  hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing.

Authors:  Chung-Fan Lee; Derick S-C Ou; Sung-Bau Lee; Liang-Hao Chang; Ruo-Kai Lin; Ying-Shiuan Li; Anup K Upadhyay; Xiaodong Cheng; Yi-Ching Wang; Han-Shui Hsu; Michael Hsiao; Cheng-Wen Wu; Li-Jung Juan
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

4.  Crystal Structure of the Golgi-Associated Human Nα-Acetyltransferase 60 Reveals the Molecular Determinants for Substrate-Specific Acetylation.

Authors:  Svein Isungset Støve; Robert S Magin; Håvard Foyn; Bengt Erik Haug; Ronen Marmorstein; Thomas Arnesen
Journal:  Structure       Date:  2016-06-16       Impact factor: 5.006

5.  Expression, crystallization and preliminary X-ray crystallographic analyses of two N-terminal acetyltransferase-related proteins from Thermoplasma acidophilum.

Authors:  Sang Hee Han; Jun Yong Ha; Kyoung Hoon Kim; Sung Jin Oh; Do Jin Kim; Ji Yong Kang; Hye Jin Yoon; Se-Hee Kim; Ji Hae Seo; Kyu-Won Kim; Se Won Suh
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-20

6.  Application of reverse-phase HPLC to quantify oligopeptide acetylation eliminates interference from unspecific acetyl CoA hydrolysis.

Authors:  Rune Evjenth; Kristine Hole; Mathias Ziegler; Johan R Lillehaug
Journal:  BMC Proc       Date:  2009-08-04

7.  Composition and biological significance of the human Nalpha-terminal acetyltransferases.

Authors:  Kristian K Starheim; Darina Gromyko; Rolf Velde; Jan Erik Varhaug; Thomas Arnesen
Journal:  BMC Proc       Date:  2009-08-04

Review 8.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

9.  Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.

Authors:  Hsu-Ping Kuo; Dung-Fang Lee; Weiya Xia; Chien-Chen Lai; Long-Yuan Li; Mien-Chie Hung
Journal:  Biochem Biophys Res Commun       Date:  2009-08-28       Impact factor: 3.575

10.  Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.

Authors:  Dong Hoon Shin; Yang-Sook Chun; Kyoung-Hwa Lee; Hyun-Woo Shin; Jong-Wan Park
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.